Selected Drugs Clear All
MultiCheck Results
- 6
Interactions
Avoid/Use Alternative |
||
|
Camcevi
(leuprolide) + Ponvory
(ponesimod) |
||
Avoid/Use Alternativeleuprolide + ponesimod PROSTATE CANCER: use alternative or monitor HR, ECG, electrolytes; ALL OTHER INDICATIONS: consider monitoring ECG, electrolytes: combo may incr. risk of bradycardia, AV block, QT prolongation, cardiac arrhythmias (additive effects, androgen deprivation may prolong QT) |
||
Monitor/Modify Tx |
||
|
deflazacort
(generic) + Ponvory
(ponesimod) |
||
Monitor/Modify Txdeflazacort + ponesimod monitor BP; caution advised during and x1-2wk after ponesimod tx: combo may incr. risk of HTN, serious infection; infection risk may be prolonged (additive effects) |
||
|
deflazacort
(generic) + Symbravo
(meloxicam/ rizatriptan) |
||
Monitor/Modify Txdeflazacort + meloxicam monitor BP, bleeding or thrombosis s/sx; use lowest effective meloxicam dose, shortest effective tx duration: combo may incr. risk of GI ulceration, perforation, bleeding (including life-threatening), thromboembolism, HTN (additive effects) deflazacort + rizatriptan monitor BP: combo may incr. risk of HTN (additive effects) |
||
|
Ponvory
(ponesimod) + Symbravo
(meloxicam/ rizatriptan) |
||
Monitor/Modify Txponesimod + meloxicam monitor BP: combo may incr. risk of HTN (additive effects) ponesimod + rizatriptan monitor BP: combo may incr. risk of HTN (additive effects) |
||
Additional Considerations |
||
|
rizatriptan
in Symbravo
|
||
|
add MAO inhibitor to Interaction Check if recent (14 days) use |
||